# A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma

> **NCT07063888** · PHASE2 · RECRUITING · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 66 (estimated)

## Conditions studied

- Intrahepatic Cholangiocarcinoma (Icc)
- Adjuvant Chemoradiotherapy
- Narrow Margin
- Lymph Node Involvement

## Interventions

- **RADIATION:** Adjuvant Concurrent Chemoradiotherapy with Simultaneous Integrated Boost

## Key facts

- **NCT ID:** NCT07063888
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-16
- **Primary completion:** 2028-05-15
- **Final completion:** 2028-05-15
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2025-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07063888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07063888, "A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07063888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*